Outcomes Network Graph
Outcomes Flow Chart
Treatment Effectiveness
User reported effectiveness ratings Lorazepam for various conditions.
| Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Panic Disorder | 57% | 29% | 0% | 7% | 7% | 14 |
| Restless Legs Syndrome | 13% | 31% | 0% | 50% | 6% | 16 |
Outcomes
Below is the degree of change seen after Lorazepam is higher than average.
|
|
Don't see what you're looking for?
Create a study and help us eradicate suffering!
Daily Distribution
Average by Year
Average by Month
Average by Day of Week
Outcomes Label
Lorazepam Info
| Property | Value |
|---|---|
| Variable Name | Lorazepam |
| Aggregation Method | SUM |
| Analysis Performed At | 2020-10-09 |
| Duration of Action | 21 days |
| Filling Value | 0 |
| Kurtosis | 13.601244633503 |
| Mean | 0.33285025 count |
| Median | 0.25 count |
| Minimum Allowed Value | 0 count |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 3 |
| Number of Measurements | 12 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 12 |
| Public | true |
| Onset Delay | 30 minutes |
| Standard Deviation | 0.22447848799587 |
| Unit | Count |
| User Variables | 6 |
| UPC | 811426923497 |
| Variable Category | Treatments |
| Variable ID | 94228 |
| Variance | 0.075906396470913 |